Evidence map›Paper›PMID 34993358›Full record

ArticleChem2021

Mucin-mimetic glycan arrays integrating machine learning for analyzing receptor pattern recognition by influenza A viruses.

Taryn M Lucas, Chitrak Gupta, Meghan O Altman, Emi Sanchez, Matthew R Naticchia, Pascal Gagneux, Abhishek Singharoy, Kamil Godula

Open access · greenAbstract read
In one paragraph

Article in Chem, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Serum antibody screening using glycan arrays.Chemical Society reviews · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. LectinOracle: A Generalizable Deep Learning Model for Lectin-Glycan Binding Prediction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Taryn M LucasDepartment of Chemistry and Biochemistry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093.
Chitrak GuptaSchool of Molecular Sciences, Arizona State University, Tempe, AZ 85281.
Meghan O AltmanDepartment of Pathology, Division of Comparative Pathology and Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093.
Emi SanchezDepartment of Chemistry and Biochemistry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093.
Matthew R NaticchiaDepartment of Chemistry and Biochemistry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093.
Pascal GagneuxDepartment of Pathology, Division of Comparative Pathology and Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093.
Abhishek SingharoySchool of Molecular Sciences, Arizona State University, Tempe, AZ 85281.
Kamil GodulaDepartment of Chemistry and Biochemistry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093.
University of California, San Diego · USArizona State University · US

Funding

In vivo glycan engineering at the cell-matrix interface to control stem cell fateDP2HD087954 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GODULA, KAMIL · 2015 to 2015
$2.3M
Chemical Biology Interfaces at UC San DiegoT32GM112584 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BURKART, MICHAEL D. · 2015 to 2019
$729k
Glycan array for phenotype-driven capture and genotyping of viruses in primary isolatesR21AI129894 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GAGNEUX, PASCAL, GODULA, KAMIL · 2016 to 2017
$601k
NIAID NIH HHS R21 AI129894NICHD NIH HHS DP2 HD087954NIGMS NIH HHS T32 GM112584
6 · The paper itself

Abstract

Influenza A viruses (IAVs) exploit host glycans in airway mucosa for entry and infection. Detection of changes in IAV glycan-binding phenotype can provide early indication of transmissibility and infection potential. While zoonotic viruses are monitored for mutations, the influence of host glycan presentation on viral specificity remains obscured. Here, we describe an array platform which uses synthetic mimetics of mucin glycoproteins to model how receptor presentation and density in the mucinous glycocalyx may impact IAV recognition. H1N1 and H3N2 binding in arrays of α2,3- and α2,6-sialyllactose receptors confirmed their known sialic acid-binding specificities and revealed their different sensitivities to receptor presentation. Further, the transition of H1N1 from avian to mammalian cell culture improved the ability of the virus to recognize mucin-like displays of α2,6-sialic acid receptors. Support vector machine (SVM) learning efficiently characterized this shift in binding preference and may prove useful to study viral evolution to a new host.

Indexed as

glycan arrayhemagglutininInfluenza Amachine learningmucinreceptor pattern

Identifiers

PMID34993358
PMCPMC8726012
OpenAlexW3209748011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.